logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Liposarcoma

    FiltersReset Filters
    5 results

    • eribulin mesylate

      (Eribulin Mesylate)
      Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
      Usage: Eribulin mesylate injection is indicated for treating metastatic breast cancer in patients who have received at least two prior chemotherapeutic regimens, including an anthracycline and a taxane. It is also used for unresectable or metastatic liposarcoma in those who have received a prior anthracycline-containing regimen.

    • eribulin mesylate

      (eribulin mesylate)
      Apotex Corp.
      Usage: Eribulin mesylate injection is indicated for treating metastatic breast cancer in patients who have undergone at least two prior chemotherapy regimens, including anthracycline and taxane, and for unresectable or metastatic liposarcoma following an anthracycline-containing regimen.

    • eribulin mesylate

      (Eribulin Mesylate)
      Baxter Healthcare Corporation
      Usage: Eribulin Mesylate Injection is indicated for treating metastatic breast cancer in patients who have received at least two prior chemotherapy regimens, including an anthracycline and a taxane. It is also indicated for unresectable or metastatic liposarcoma in patients previously treated with an anthracycline-containing regimen.

    • halaven

      (eribulin mesylate)
      Eisai Inc.
      Usage: HALAVEN is indicated for treating metastatic breast cancer in patients who have received at least two prior chemotherapy regimens, including anthracyclines and taxanes, and for unresectable or metastatic liposarcoma in patients previously treated with an anthracycline-containing regimen.

    • yondelis

      (Trabectedin)
      Janssen Products, LP
      Usage: YONDELIS® is indicated for treating patients with unresectable or metastatic liposarcoma or leiomyosarcoma who have previously received an anthracycline-containing regimen.